Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “cells”

914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 914
Index total 30,257
Page 10 / 39

Quick answer

This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

914 results for “cells” · 30,257 patents in full index Clear search

  1. US 11298424

    Non-ionic and thermoresponsive diblock copolypeptide hydrogels for delivery of molecules and cells

    The Regents of the University of California · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  2. US 11298378

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    CRISPR THERAPEUTICS AG · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  3. US 11299549

    Humanized BCMA antibody and BCMA-CAR-T cells

    Caribou Biosciences, Inc. · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  4. US 11299711

    Production of fully functional mature beta cells from human pancreatic progenitors

    The Regents of the University of California · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  5. US 11293010

    Methods of producing modified natural killer cells and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted

  6. US 11286279

    Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions

    The Regents of the University of California · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted

  7. US 11286291

    Co-stimulatory domains for use in genetically-modified cells

    Precision BioSciences, Inc. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted

  8. US 11286463

    Reprogramming of aged adult stem cells

    Advanced ReGen Medical Technologies, LLC · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted

  9. US 11278572

    Reducing CXCR4 expression and/or function to enhance engraftment of hematopoietic stem cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted

  10. US 11273182

    Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease

    Takeda Pharmaceutical Company Limited · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted

  11. US 11268065

    Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

    Precision BioSciences, Inc. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted

  12. US 11261432

    Method and composition for inducing human pluripotent stem cells

    The Regents of the University of California · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted

  13. US 11246940

    Peptides whose uptake in cells is controllable

    The Regents of the University of California · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted

  14. US 11241460

    Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells

    Astellas Institute for Regenerative Medicine · Granted Feb 8, 2022 · Expires Feb 3, 2042

    granted

  15. US 11242510

    Mammalian cells devoid of lactate dehydrogenase activity

    The Regents of the University of California · Granted Feb 8, 2022 · Expires Feb 3, 2042

    granted

  16. US 11234418

    Genetically modified cells, tissues, and organs for treating disease

    Regents of the University of Minnesota · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  17. US 11207687

    Artificial cells

    University College Cardiff Consultants Limited · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  18. US 11207351

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    CRISPR THERAPEUTICS AG · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  19. US 11208493

    Internalizing human monoclonal antibodies targeting prostate and other cancer cells

    The Regents of the University of California · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  20. US 11202802

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    CRISPR THERAPEUTICS AG · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted

  21. US 11191783

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    CRISPR THERAPEUTICS AG · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

  22. US 11185572

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  23. US 11186822

    Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

    Precision BioSciences, Inc. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  24. US 11174495

    Reporter system for detecting and targeting activated cells

    The Board of Regents of the University of Texas System · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.